The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Signatory on data file letter
-
Good afternoon! Quick question, are there any requirements for signatory on a Data on File letter? Thank you!
-
Good afternoon! Quick question, are there any requirements for signatory on a Data on File letter? Thank you!
Hello @joao-borges
In general, the letter should be signed by someone from medical or regulatory within the sponsor’s company. There may be situations where a different signature is required. This would be addressed during the review process.
